Leslie's Proxy Proposes Ratifying Ernst & Young as Auditor, Contradicting Recent Switch to Grant Thornton

summarizeSummary

Leslie's, Inc. filed its definitive proxy statement, notably proposing to ratify Ernst & Young LLP as its auditor, directly contradicting its recent 8-K announcing a switch to Grant Thornton, amidst other significant governance and equity incentive plan proposals.

check_boxKey Events

• Contradictory Auditor Proposal

  The company proposes shareholders ratify Ernst & Young LLP as its independent auditor, directly conflicting with the 8-K filed on January 30, 2026, which announced a change to Grant Thornton LLP.

• Equity Incentive Plan Approval Sought

  Shareholders are asked to approve the Leslie's, Inc. Amended and Restated 2020 Omnibus Incentive Plan, which could lead to further dilution for a company trading at distressed levels.

• Removal of Supermajority Voting Requirements

  The filing includes a proposal to amend the Certificate of Incorporation to remove and replace supermajority voting requirements, potentially altering corporate governance dynamics.

• Director Nominations

  The proxy statement nominates Seth Estep, Loma Nagler, John Strainr, and John Hartmann for election to the Board of Directors, with John Hartmann having been recently appointed on January 8, 2026.

auto_awesomeAnalysis

This definitive proxy statement (DEFA14A) presents a critical contradiction regarding Leslie's, Inc.'s independent auditor. Just days ago, on January 30, 2026, the company filed an 8-K announcing a change from Ernst & Young LLP to Grant Thornton. However, this DEFA14A proposes that shareholders ratify Ernst & Young LLP for the fiscal year ending October 3, 2026. This discrepancy raises significant concerns about the company's corporate governance, internal controls, and financial reporting integrity, especially following the preliminary proxy statement on January 21, 2026, which revealed un-remediated material weaknesses in internal controls. The filing also seeks approval for an Amended and Restated 2020 Omnibus Incentive Plan, which could be dilutive, and amendments to remove supermajority voting requirements, potentially centralizing power. These developments occur while the stock is trading near its 52-week low, highlighting the company's distressed state and the urgency of these governance and capital decisions.